Skip to main content
OpenTrials
Completed

NCT Number: NCT06015919

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Postmenopausal Disorder

Age range

50 year–60 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Alaa Nabil Elsayed Mohamed

Abū Ḩammād, Elsharqia, 44661, Egypt

About this study

45 of post menopausal women divided into three groups A,B,C

  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Their body mass index will be ranged from 25 -29.9 kg/m2
  • All patients will be medically stable when attending the study.
  • The DASH eating plan of 1800 kcal per day will be used in the study.

Exclusion criteria

  • Auditory and visual problems.
  • Chronic renal failure.
  • Myocardial infarction or arrythmias with heart failure.

Treatment and study plan

DASH diet

Behavioral
  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

acupuncture

Device

acupuncture

Primary outcomes

  1. blood pressure

    Time frame: 3 months

    it will be measured by sphygmomanometer pre and post treatment

Secondary outcomes

  1. sodium and potassium levels

    Time frame: 3 months

    it will be measured by blood analysis pre and post treatment

Other outcomes

  1. assessment of quality of life

    Time frame: 3 months

    it will be measured by sf 36 questionnaire pre and post treatment

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Collaborators

  • faculty of physical therapy

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Aug 29, 2023
Registry last updated
Aug 29, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.